110 related articles for article (PubMed ID: 14552799)
1. Sulphonamide-based small molecule VLA-4 antagonists.
Stasiak M; Mehlin C; Boni E; Vaisar T; Little T; Kim HO; Qabar M
Bioorg Med Chem Lett; 2003 Nov; 13(21):3875-8. PubMed ID: 14552799
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of eosinophilia in vivo by a small molecule inhibitor of very late antigen (VLA)-4.
Okigami H; Takeshita K; Tajimi M; Komura H; Albers M; Lehmann TE; Rölle T; Bacon KB
Eur J Pharmacol; 2007 Mar; 559(2-3):202-9. PubMed ID: 17234179
[TBL] [Abstract][Full Text] [Related]
3. N-Tetrahydrofuroyl-(L)-phenylalanine derivatives as potent VLA-4 antagonists.
Yang GX; Chang LL; Truong Q; Doherty GA; Magriotis PA; de Laszlo SE; Li B; MacCoss M; Kidambi U; Egger LA; McCauley E; Van Riper G; Mumford RA; Schmidt JA; Hagmann WK
Bioorg Med Chem Lett; 2002 Jun; 12(11):1497-500. PubMed ID: 12031328
[TBL] [Abstract][Full Text] [Related]
4. Arylsulfonamide pyrimidines as VLA-4 antagonists.
Xu YZ; Konradi AW; Bard F; Dappen M; Dofiles L; Dreyer M; Gallager I; Garrido C; Krimm M; Liao Z; Messersmith E; Mutter L; Pleiss MA; Samant B; Semko CM; Smith J; Stappenbeck F; Stupi B; Vandervert C; Welch B; Wipke B; Yednock T
Bioorg Med Chem Lett; 2013 May; 23(10):3070-4. PubMed ID: 23562062
[TBL] [Abstract][Full Text] [Related]
5. The identification and optimization of orally efficacious, small molecule VLA-4 antagonists.
Huryn DM; Konradi AW; Ashwell S; Freedman SB; Lombardo LJ; Pleiss MA; Thorsett ED; Yednock T; Kennedy JD
Curr Top Med Chem; 2004; 4(14):1473-84. PubMed ID: 15544538
[TBL] [Abstract][Full Text] [Related]
6. Highly constrained bicyclic VLA-4 antagonists.
Chang LL; Truong Q; Doss GA; MacCoss M; Lyons K; McCauley E; Mumford R; Forrest G; Vincent S; Schmidt JA; Hagmann WK
Bioorg Med Chem Lett; 2007 Feb; 17(3):597-601. PubMed ID: 17118652
[TBL] [Abstract][Full Text] [Related]
7. Substituted tetrahydrofuroyl-1-phenylalanine derivatives as potent and specific VLA-4 antagonists.
Doherty GA; Yang GX; Borges E; Chang LL; MacCoss M; Tong S; Kidambi U; Egger LA; McCauley E; Van Riper G; Mumford RA; Schmidt JA; Hagmann WK
Bioorg Med Chem Lett; 2002 Jun; 12(11):1501-5. PubMed ID: 12031329
[TBL] [Abstract][Full Text] [Related]
8. Effects of the very late adhesion molecule 4 antagonist WAY103 on human peripheral blood eosinophil vascular cell adhesion molecule 1-dependent functions.
Sedgwick JB; Jansen KJ; Kennedy JD; Kita H; Busse WW
J Allergy Clin Immunol; 2005 Oct; 116(4):812-9. PubMed ID: 16210055
[TBL] [Abstract][Full Text] [Related]
9. Identification of trans-4-[1-[[7-fluoro-2-(1-methyl-3-indolyl)-6-benzoxazolyl]acetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid as a potent, orally active VLA-4 antagonist.
Setoguchi M; Iimura S; Sugimoto Y; Yoneda Y; Chiba J; Watanabe T; Muro F; Iigo Y; Takayama G; Yokoyama M; Taira T; Aonuma M; Takashi T; Nakayama A; Machinaga N
Bioorg Med Chem; 2012 Feb; 20(3):1201-12. PubMed ID: 22261021
[TBL] [Abstract][Full Text] [Related]
10. Aza-bicyclic amino acid sulfonamides as alpha(4)beta(1)/alpha(4)beta(7) integrin antagonists.
Dyatkin AB; Hoekstra WJ; Kinney WA; Kontoyianni M; Santulli RJ; Kimball ES; Fisher MC; Prouty SM; Abraham WM; de Garavilla L; Andrade-Gordon P; Hlasta DJ; He W; Hornby PJ; Damiano BP; Maryanoff BE
Bioorg Med Chem Lett; 2004 Feb; 14(3):591-6. PubMed ID: 14741249
[TBL] [Abstract][Full Text] [Related]
11. N-isonicotinoyl-(L)-4-aminophenylalanine derivatives as tight binding VLA-4 antagonists.
Doherty GA; Yang GX; Borges E; Tong S; McCauley ED; Treonz KM; Van Riper G; Pacholok S; Si Q; Koo GC; Shah K; Mumford RA; Hagmann WK
Bioorg Med Chem Lett; 2003 Jun; 13(11):1891-5. PubMed ID: 12749892
[TBL] [Abstract][Full Text] [Related]
12. N-aryl-prolyl-dipeptides as potent antagonists of VLA-4.
Kamenecka TM; Lanza T; de Laszlo SE; Li B; McCauley ED; Van Riper G; Egger LA; Kidambi U; Mumford RA; Tong S; MacCoss M; Schmidt JA; Hagmann WK
Bioorg Med Chem Lett; 2002 Aug; 12(16):2205-8. PubMed ID: 12127538
[TBL] [Abstract][Full Text] [Related]
13. Discovery and evaluation of terephthalic acid derivatives as potent alpha4beta1 integrin antagonists.
Müller G; Albers M; Hessler G; Lehmann TE; Okigami H; Tajimi M; Bacon K; Rölle T
J Enzyme Inhib Med Chem; 2003 Aug; 18(4):309-12. PubMed ID: 14567545
[TBL] [Abstract][Full Text] [Related]
14. Role of the Mac-1 and VLA-4 integrins, and concomitant Th2-cytokine production, in nitric oxide modulated eosinophil migration from bone marrow to lungs in allergic mice.
Pelaquini EH; Guimarães Lde A; Benetti LR; Fernandes LG; Tamashiro WM; Conran N; Ferreira HH
Int Immunopharmacol; 2011 Feb; 11(2):204-11. PubMed ID: 21111080
[TBL] [Abstract][Full Text] [Related]
15. Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptide.
Dutta AS; Crowther M; Gormley JJ; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Jamieson A; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
J Pept Sci; 2000 Jul; 6(7):321-41. PubMed ID: 10946997
[TBL] [Abstract][Full Text] [Related]
16. 4-(Pyrrolidinyl)methoxybenzoic acid derivatives as a potent, orally active VLA-4 antagonist.
Chiba J; Iimura S; Yoneda Y; Sugimoto Y; Horiuchi T; Muro F; Ochiai Y; Ogasawara T; Tsubokawa M; Iigou Y; Takayama G; Taira T; Takata Y; Yokoyama M; Takashi T; Nakayama A; Machinaga N
Chem Pharm Bull (Tokyo); 2006 Nov; 54(11):1515-29. PubMed ID: 17077548
[TBL] [Abstract][Full Text] [Related]
17. Pyridone derivatives as potent and selective VLA-4 integrin antagonists.
Witherington J; Bordas V; Gaiba A; Green PM; Naylor A; Parr N; Smith DG; Takle AK; Ward RW
Bioorg Med Chem Lett; 2006 Apr; 16(8):2256-9. PubMed ID: 16455247
[TBL] [Abstract][Full Text] [Related]
18. The role of VLA-4 binding for experimental melanoma metastasis and its inhibition by heparin.
Schlesinger M; Roblek M; Ortmann K; Naggi A; Torri G; Borsig L; Bendas G
Thromb Res; 2014 May; 133(5):855-62. PubMed ID: 24636486
[TBL] [Abstract][Full Text] [Related]
19. VLA-4 antagonists: potent inhibitors of lymphocyte migration.
Yang GX; Hagmann WK
Med Res Rev; 2003 May; 23(3):369-92. PubMed ID: 12647315
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory activity of c(ILDV-NH(CH2)5CO), a novel, selective, cyclic peptide inhibitor of VLA-4-mediated cell adhesion.
Haworth D; Rees A; Alcock PJ; Wood LJ; Dutta AS; Gormley JJ; Jones HB; Jamieson A; Reilly CF
Br J Pharmacol; 1999 Apr; 126(8):1751-60. PubMed ID: 10372817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
